Clinical trial
Continuous Assessment of Risk and Efficacy (CARE) Using Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
NCT06028139 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Assessment of Risk and Efficacy (CARE) Using Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
- Lead sponsor
- Singapore General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 24, 2023
- Completion date
- December 31, 2024
- Enrollment
- 400 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.